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Abstract
Neuroimaging has played an important part in advancing our understanding of the
neurobiology of obsessive–compulsive disorder (OCD). At the same time, neuroim-
aging studies of OCD have had notable limitations, including reliance on relatively
small samples. International collaborative efforts to increase statistical power by
combining samples from across sites have been bolstered by the ENIGMA consor-
tium; this provides specific technical expertise for conducting multi-site analyses, as
well as access to a collaborative community of neuroimaging scientists. In this arti-
cle, we outline the background to, development of, and initial findings from
ENIGMA's OCD working group, which currently consists of 47 samples from
34 institutes in 15 countries on 5 continents, with a total sample of 2,323 OCD
patients and 2,325 healthy controls. Initial work has focused on studies of cortical
thickness and subcortical volumes, structural connectivity, and brain lateralization
in children, adolescents and adults with OCD, also including the study on the com-
monalities and distinctions across different neurodevelopment disorders. Additional
work is ongoing, employing machine learning techniques. Findings to date have
contributed to the development of neurobiological models of OCD, have provided
an important model of global scientific collaboration, and have had a number of clin-
ical implications. Importantly, our work has shed new light on questions about
whether structural and functional alterations found in OCD reflect neu-
rodevelopmental changes, effects of the disease process, or medication impacts.
We conclude with a summary of ongoing work by ENIGMA-OCD, and a consider-
ation of future directions for neuroimaging research on OCD within and beyond
ENIGMA.
K E YWORD S
cortical thickness, ENIGMA, mega-analysis, meta-analysis, MRI, obsessive–compulsive
disorder, surface area, volume
1 | BACKGROUND
Since the 1980s, obsessive–compulsive disorder (OCD) researchers
worldwide have made extensive use of neuroimaging (Behar et al.,
1984; Luxenberg et al., 1988). OCD has a distinctive phenotype,
with characteristic repetitive thoughts and intrusions (obsessions)
and habitual behaviors (compulsions), and there was early evidence
of the involvement of specific brain circuits and systems (Cummings,
1995). Early hypotheses regarding brain systems involved were
based on clinical observations, including descriptions of OCD-like
behaviors in patients with subcortical disorders, such as
Huntington's disease (Cummings & Cunningham, 1992), Sydenham's
chorea (Swedo, Rapoport, Cheslow, & Ayoub, 1989), and pallidal
(Laplane et al., 1989) and frontal lobe (Eslinger & Damasio, 1985)
lesions. Data obtained with human brain imaging in the late 1980s
allowed detailed neurobiological models of OCD to be developed.
These models initially focused on the striatum and orbitofrontal cor-
tex, but were later refined to include more broadly interacting
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fronto-striatal, fronto-parietal, fronto-limbic, and cerebellar circuits
(Stein et al., 2019; Van den Heuvel et al., 2016).
The first brain imaging studies in OCD focused on brain mor-
phometry and glucose metabolism, using computed tomography
(CT) (e.g., Behar et al., 1984), single photon emission computed
tomography (SPECT) and positron emission tomography (PET)
(e.g., Rubin, Anath, Villanueva-Meyer, Trajmar, & Mena, 1995). In the
1990s, magnetic resonance imaging (MRI) began to dominate the
field. High resolution structural MRI enabled morphometric analyses
of subcortical volume and shape, cortical thickness and surface area,
as well as cortical gyrification. Functional MRI (fMRI) began to be
used to visualize brain activation patterns during specific states rele-
vant to the disorder, using a range of emotional and cognitive para-
digms that may be crucial in the disease, for example, symptom
provocation (Jaspers-Fayer et al., 2019; Thorsen et al., 2018), fear
and extinction learning (Milad et al., 2013), response inhibition
(Norman et al., 2019), planning (e.g., Van den Heuvel et al., 2005),
working memory (e.g., De Vries et al., 2014), and reversal learning
(e.g., Remijnse et al., 2006).
In the past decade, imaging designs began to shift from analyzing
specific regions of interest to studying whole-brain networks. Net-
work approaches can be used to examine structural connectivity,
using diffusion weighted imaging (DTI; Piras, Piras, Caltagirone, &
Spalletta, 2013; Radua et al., 2014) as well as structural covariance
(Yun et al., 2020), and functional connectivity at rest (Gursel, Avram,
Sorg, Brandl, & Koch, 2018) and during task performance (e.g., Douw
et al., 2019). As with other neuroimaging studies, a key challenge has
been the reproducibility of research findings, as most single center
imaging studies have limited statistical power to detect effects of the
disorder, while adequately controlling for multiple comparisons and
heterogeneity in demographic and clinical characteristics. Although
each individual study differs in the choice of paradigms, a structural
MRI scan is typically part of every study design, enabling meta-
analyses of data across many samples, or mega-analyses of pooled
raw MRI scans or MRI-extracted measures. Although technically more
challenging, meta-analyses and mega-analyses of resting state fMRI
(rsfMRI), and even task-based fMRI, are also possible (Adhikari et al.,
2018; Adhikari et al., 2019; Yan et al., 2019).
1.1 | The first worldwide data-sharing initiative:
The OCD brain imaging consortium
The first large single-center structural MRI study of OCD was publi-
shed in 2004 by Pujol et al., based on MRI scans of 72 OCD patients
and 72 controls, using voxel-based morphometry (VBM) (Ashburner &
Friston, 2000; Pujol et al., 2004). Compared to healthy controls, OCD
patients had, on average, smaller volumes for the medial frontal gyrus,
medial orbitofrontal cortex and left insula-operculum, and greater vol-
umes for the ventral part of the putamen and anterior cerebellum.
The striatal finding was mainly driven by older patients and those with
longer disease duration. Pujol et al. (2004) also found that although
these frontal-striatal abnormalities were present across the various
subtypes of OCD, specific phenotypes showed additional neural alter-
ations: aggressive obsessions and checking compulsions were associ-
ated with smaller right amygdala. Subsequently, these effects were
largely replicated by the symptom dimension findings of Van den
Heuvel et al. (2009).
Multiple conventional meta-analyses of VBM studies of
OCD were subsequently published (Radua & Mataix-Cols, 2009;
Radua, van den Heuvel, Surguladze, & Mataix-Cols, 2010; Rotge
et al., 2010; Peng et al., 2012), using statistical methods to aggregate
information on effect sizes, standard errors, and confidence intervals
from primary published studies, in order to estimate overall effect
size. To meta-analyze voxel-based data, an often-used approach is
the signed differential mapping (SDM) method, developed by Radua
(https://www.sdmproject.com). A meta-analysis using this method
showed that compared to healthy controls, OCD patients have, on
average, lower volumes of the dorsomedial prefrontal cortex
(dmPFC)/dorsal anterior cingulate cortex (dACC) and greater volume
of the bilateral striatum (mainly anterior putamen, extending into the
caudate nucleus) (Radua & Mataix-Cols, 2009). In comparison to
other anxiety disorders, smaller volume of the dmPFC/dACC was
found across disorders, whereas OCD patients had greater pallidal
volume than did patients with anxiety disorders (Radua et al., 2010).
An even larger cross-disorder meta-analysis of brain volume across
mental disorders, including 193 studies (15,892 subjects) in six diag-
nostic groups (schizophrenia, bipolar disorder, major depressive disor-
der, substance use disorder, OCD, and anxiety disorders) showed
that smaller volume of the dACC and bilateral insula/operculum was
not specific to OCD, but was consistently present across all these
psychiatric disorders (Goodkind et al., 2015).
These aggregate meta-analyses, based on published data, were
highly informative, but still prone to publication bias, selective
reporting in primary studies, large variations in data processing and
analyses across studies influencing the results, and insufficient power
to undertake detailed investigations of the associations between clini-
cal characteristics and neuroimaging findings (Boedhoe et al., 2019).
To address these limitations, the OCD Brain Imaging Consortium
(OBIC) was initiated in 2010; this initiative aimed to increase statisti-
cal power by pooling raw MRI data from centers around the world.
Harmonization of data quality control and data processing, all per-
formed at a single center, would limit variation across data samples to
just the variation in inclusion criteria and data acquisition. Six aca-
demic OCD centers (from Asia, Europe, and South America) provided
high-quality data from 412 adult OCD patients and 368 healthy con-
trols. Using VBM, the OBIC consortium mega-analysis showed that
compared to healthy controls, OCD patients had lower volume of the
dmPFC, dACC, and bilateral insula-operculum, largely replicating pre-
vious meta-analytic findings (Goodkind et al., 2015; Radua et al.,
2010; Radua & Mataix-Cols, 2009), as well as greater volume of the
cerebellum. Group-by-age interaction effects illustrated that some
regions (e.g., putamen) show a relative preservation of volume in OCD
with increasing age while other regions (e.g., temporal regions) show a
relative loss of volume in OCD with increasing age. These findings are
consistent with the initial study by Pujol et al. (2004), and suggest that
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increased volume of the striatum/pallidum is most prominent in older
OCD patients, perhaps related to disease chronicity.
Using the same OBIC dataset, structural covariance analysis of
four striatal regions and two amygdala regions was performed, show-
ing increased covariance between the volume of the ventral-rostral
putamen and the left inferior frontal gyrus/operculum. Consistent
with the previous findings, this association was only significant in
older OCD patients, suggesting that these alterations may develop
over the course of the disease (Subira et al., 2016). In addition to this
fronto-striatal finding, increased covariance was found between the
right centromedial-superficial part of the amygdala and the ventrome-
dial prefrontal cortex, consistent with the role of the limbic circuit in
OCD, as evident in functional MRI studies on emotional processing in
this disorder (Milad et al., 2013; Thorsen et al., 2018).
Whereas VBM measures volume or gray matter density in cortical
regions at the voxel level (Ashburner & Friston, 2000), surface-based
methods such as FreeSurfer calculate morphometric measures from
geometric models of the cortical surface (Fischl & Dale, 2000). Abnor-
malities in regional volume as measured with VBM can be the result
of altered cortical thickness (CTh), surface area (SA), cortical folding,
or a combination of these. Whereas cortical thickness changes
dynamically across the lifespan as a consequence of development, dis-
ease and environmental factors (Eyler et al., 2011; Frye et al., 2010),
surface area and cortical folding are more indicative of early neuro-
development (Mangin, Jouvent, & Cachia, 2010). Atlas-based
approaches as used in FreeSurfer and voxel-based approaches as used
in VBM also differ in their approach to and interpretation of subcorti-
cal regions: Whereas VBM detects density differences at the voxel-
level, global or regional differences in subcortical structures can be
inferred from atlas-based FreeSurfer analyses. Using exactly the same
OBIC sample as was used in the VBM mega-analysis (De Wit et al.,
2014), Fouche et al. (2017) used vertex-wise FreeSurfer to compare
cortical thickness and subcortical volumes in patients versus controls,
and showed that adult OCD patients have a thinner cortex in a num-
ber of frontal, temporal, and parietal regions and smaller bilateral hip-
pocampus. These findings partly overlap with the VBM-based results,
but also show that results and their interpretation depend to some
extent on the methods used.
1.2 | Extension to children and better worldwide
coverage: The ENIGMA-OCD consortium
In 2009, Paul Thompson initiated the ENIGMA (Enhancing Neuroim-
aging and Genetics through Meta-analysis) consortium. ENIGMA has
now grown to a collaboration of more than 1,400 scientists from
43 countries studying the human brain, both in health and disease
(Thompson et al., 2019). The initial aim was to perform large-scale
neuroimaging genetics analyses, by pooling worldwide data, resources
and expertise, to answer clinical and fundamental questions related to
psychiatric and neurological disorders. The consortium currently has
30 working groups on specific psychiatric and neurological disorders,
a few on trans-diagnostic constructs (e.g., irritability, suicidality, and
lifespan), and 12 that develop and disseminate analysis pipelines, to
facilitate harmonization across working groups.
With the goals of obtaining larger sample sizes than represented
in OBIC, increasing worldwide coverage, extending the samples to
pediatric OCD, comparing OCD to other disorders, and eventually
combining imaging data and genetics, van den Heuvel and Stein pro-
posed adding an ENIGMA-OCD working group to the ENIGMA con-
sortium in 2013. As of 2019, ENIGMA-OCD consists of 47 samples
from 34 institutes in 15 countries on 5 continents, with a total sample
of 4,648 with MRI data of 2,323 OCD patients (1,824 adults
(>18 years), 359 adolescents (12–17 years), 140 children (<12 years))
and 2,325 controls (1,724 adults, 325 adolescents, and 166 children;
Figure 1).
The standard procedure in ENIGMA has been collation of
individual-participant data (IPD; e.g., value of CTh, SA, subcortical
volume, and intracranial volume) from multiple studies, without
requiring the sharing or centralization of the raw MRI data, as was
done in OBIC. The advantage of meta-analysis on IPD without the
need to exchange raw data is of particular relevance in the context
of the new European law, that is, the General Data Protection Reg-
ulation 2016/679, regulating data protection and privacy for all
individual citizens of the European Union (https://gdpr-info.eu/).
Using standardized protocols for data processing and quality control
(see also: http://enigma.ini.usc.edu/protocols/), all data are
processed at each site locally. Standardization of protocols, within
working groups and across working groups, ensures low methodo-
logical heterogeneity across sites and working groups. IPD can sub-
sequently be used in two different statistical approaches: A two-
stage or a one-stage approach (Boedhoe et al., 2019). In the two-
stage approach, IPD are first analyzed for each sample separately to
obtain summary results (e.g., effect size estimates, confidence inter-
vals, and so on), which are then used for standard meta-analysis. In
contrast, the one-stage approach analyzes all IPD in one statistical
model, while accounting for site effects, to estimate the overall
effect. In the ENIGMA-OCD publications we call the two-stage
approach meta-analysis, and the one-stage approach mega-analysis.
Whereas in OBIC we conducted mega-analyses on the raw MRI
data—all processed at a single site—in ENIGMA-OCD we conducted
both the two-stage aggregated data meta-analyses and the one-
stage IPD-based mega-analyses.
Within ENIGMA-OCD, the meta- and mega-analyses revealed
comparable findings for the subcortical regions (Boedhoe et al., 2017),
but the mega-analytic approach appeared more sensitive for detecting
subtle cortical abnormalities (Boedhoe et al., 2018). We recently
empirically evaluated whether a meta-analysis provides results com-
parable to a mega-analysis, and which of the two analytic frameworks
(multiple linear regression mega-analysis model versus linear mixed-
effects random-intercept mega-analysis model) performs better.
Effect sizes and standard error estimates (and 95% confidence
intervals), and (where possible) model fit, assessed using the Bayesian
information criterion, were used to evaluate which of the methods
performs best. Although effect sizes were similar for the meta-analysis
and linear regression mega-analysis, we showed that in the case of
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cross-sectional structural MRI data a mega-analysis performs better
than a meta-analysis (lower standard errors and narrower confidence
intervals), and in a multi-center study with moderate variation
between cohorts, a linear mixed-effects random-intercept mega-
analytical framework seems to lead to the best model fit (Boedhoe
et al., 2019).
1.3 | First findings of ENIGMA-OCD: Cortical
thickness, surface area and subcortical volume
When comparing OCD patients to healthy controls, we analyzed data
from adult subjects (18 years and older) and pediatric/adolescent sub-
jects (below 18 years), separately. For the purpose of basic compari-
sons of subcortical volume and cortical thickness and surface area, we
pooled data from children (<12 years) and adolescents (12–17 years)
in a pediatric/adolescent analysis (Boedhoe et al., 2017, 2018), but in
the subsequent cross-disorder comparisons with other child-onset
disorders (autism spectrum disorder, ASD) and attention deficit hyper-
activity disorder (ADHD), we analyzed children and adolescents sepa-
rately (Boedhoe et al., 2019).
In the subcortical analyses, we found clear differences between
the pediatric OCD patients (compared with healthy controls, n = 335
and 287, respectively) and the adult OCD patients (compared with
healthy controls, n = 1,495 and 1,472, respectively) (Boedhoe et al.,
2017). Pediatric OCD was associated with greater volume of the thal-
amus (Cohen's d = 0.38), but this effect was only detectable in
the comparison of unmedicated OCD versus healthy controls.
We recently replicated this finding with data from the Generation R
cohort (Jaddoe et al., 2010), in which children with probable OCD
(scoring above the cut-off on the short OCD screener) also had a
larger thalamus, on average (unpublished data). This may suggest
altered neurodevelopment in children prone to develop OCD. Never-
theless, the thalamus is not a uniform structure but rather consists of
multiple subnuclei, each with its own cortical connectivity profile and
functions (Behrens et al., 2003). OCD-related enlargement of the
overall thalamus may therefore be driven by one or a few subnuclei.
Which subnuclei drive this effect is currently unknown, although
shape analysis has revealed increased surface area in anterior and
pulvinar nuclei in adult OCD patients (Shaw et al., 2015). In future
studies, we will employ the recently developed and validated algo-
rithm from Iglesias et al. (2018) to segment the subnuclei of the thala-
mus and study which nuclei drive the effect.
Adult OCD patients showed smaller hippocampus (Cohen's d =
−0.13), most pronounced in patients with an adult onset of OCD
(Cohen's d = −0.18), patients with a comorbid lifetime diagnosis of
depression (Cohen's d = −0.27), and patients using medication
(Cohen's d = −0.29). Adult OCD patients also showed larger pallidum
(Cohen's d = 0.16), most pronounced in patients with a childhood
onset of OCD (Cohen's d = 0.25), and patients using medication
(Cohen's d = 0.29). The hippocampal findings do not seem to be spe-
cific to OCD, as similar results have been reported by the ENIGMA
working groups for schizophrenia (Van Erp et al., 2016), bipolar disor-
der (Hibar et al., 2016), major depressive disorder (Schmaal et al.,
2016), and posttraumatic stress disorder (Logue et al., 2018), and so
may be related to trans-diagnostic aspects of chronic distress. The pal-
lidum findings fit well with all prior meta- and mega-analyses (De Wit
et al., 2014; Peng et al., 2012; Radua et al., 2010; Radua & Mataix-
Cols, 2009; Rotge et al., 2010) and appear to be more specific to
OCD. Larger pallidum could be due to chronic compulsivity (Van den
Heuvel et al., 2016). At the same time, since larger pallidum has also
been reported in schizophrenia (Van Erp et al., 2016), use of antipsy-
chotic medication might partly explain the findings. Indeed, in our
analysis by age-group and medication class (Ivanov et al., 2019), a
F IGURE 1 World map
showing the 34 institutes
participating in the ENIGMA-
OCD consortium
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larger pallidum was seen particularly in adolescent and adult patients
taking antipsychotics.
Analyses of alterations in brain asymmetry, in partnership with
ENIGMA's Laterality working group, showed that children/adoles-
cents with OCD (n = 501) versus healthy controls (n = 439) have
altered asymmetry of the thalamus (more leftward; Cohen's d = 0.19)
and pallidum (less leftward, Cohen's d = −0.21), which was not detect-
able in adult OCD, possibly reflecting altered neurodevelopmental
processes (Kong et al., 2019; Figure 2).
The cortical analyses showed that pediatric/adolescent OCD
patients (n = 407) versus healthy control children/adolescents
(n = 324) have thinner left and right inferior parietal, left superior pari-
etal and lateral occipital cortices (Cohen's d values between −0.24
and − 0.31). Adult OCD patients (n = = 1,498), in comparison to adult
healthy controls (n = 1,436), showed a lower surface area of the trans-
verse temporal cortex (Cohen's d = −0.16) and a thinner bilateral infe-
rior parietal cortex (Cohen's d = −0.14; Boedhoe et al., 2018). The
involvement of the parietal cortex is consistent with the vertex-wise
FreeSurfer findings of the OBIC consortium (Fouche et al., 2017), and
the effect was now further found to extend to children, suggesting
altered maturation of the parietal cortex early in life that persists into
adulthood. One obvious discrepancy with previous meta- and mega-
analysis of structural MRI in OCD is the lack of involvement of the
prefrontal regions; this may reflect differences in methods used: The
atlas-based approach to cortical thickness and surface areas that has
been used in ENIGMA (segmenting whole structures using coarse
parcellation) can be less sensitive to subtle regional abnormalities than
VBM's voxel-wise registration and vertex-based approach to cortical
thickness that was used by OBIC. The use of higher-resolution
parcellation methods (e.g., Glasser et al., 2016) might give results that
are more consistent with the voxel-wise and vertex-wise approaches.
Medication status appeared to be a strong confounder (Boedhoe
et al., 2018). Compared to healthy controls (n = 324), pediatric/adoles-
cent OCD patients on medication (n = 183) had thinner inferior and
superior parietal and lateral occipital cortices (Cohen's d = −0.31) and
widespread surface area differences, mainly in frontal regions
(Cohen's d values between −0.27 and −0.33). Medicated adult OCD
patients (n = 646), in comparison to controls (n = 1,436), had wide-
spread abnormalities in cortical thickness, mainly in relation to frontal,
temporal, parietal and occipital regions (Cohen's d values between
−0.10 and −0.26, see Figure 3). Unmedicated pediatric/adolescent
(n = 222) and adult (n = 831) OCD patients did not differ from healthy
controls, on average, in cortical thickness and surface area. Medica-
tion effects were most pronounced in those patients using a combina-
tion of antidepressants and antipsychotics, and persisted after
adjusting for disease severity and co-morbidity. Although these medi-
cation effects should be interpreted with caution due to the cross-
sectional nature of the study design and lack of information on dura-
tion and dosage of medication use, they may suggest neuroplastic
effects of medication on the brain, both in children and adults. Longi-
tudinal studies of the long-term protective and potentially negative
effects of antidepressants on the developing brain are non-existent.
This knowledge gap is remarkable in the context of more than
60 years of antidepressant prescriptions. Solid conclusions on the
impact of this medication on the brain await longitudinal studies, with
detailed assessment of symptom profile, duration without treatment,
medication dosage and duration of exposure, also taking into account
the exposure to other interventions (e.g., CBT) and environmental fac-
tors (e.g., early life stress).
Using the available cross-sectional data of ENIGMA-OCD, we
studied medication effects in two additional ways. First, we used
machine learning analysis of the previously analyzed cortical and sub-
cortical measures from 2,304 OCD patients and 2,068 controls to
assess whether anatomical group differences might be used to create
a neuroimaging biomarker for OCD (Bruin et al., 2019). Classification
performance across 10 different machine and deep learning
approaches was limited, in this initial analysis that only used extracted
measures derived from anatomical MRI. With site-stratified cross-vali-
dation, the receiver operating characteristic area under the curve
(ROC-AUC) ranged between 0.57 and 0.62, and the performance
dropped to chance level (classification performance between 0.51 and
0.54) when leave-one-site-out cross-validation was used, indicating
that these anatomical brain features, on their own, are not suitable as
a biomarker for OCD. However, when patients were stratified
according to whether they currently use medication, classification per-
formance improved remarkably: Medicated OCD patients and healthy
controls could then be distinguished with a 0.73 AUC (SD = 0.03,
pcorr < .001) (in contrast to unmedicated OCD and healthy controls,
with 0.61 AUC [SD = 0.02, pcorr = .03]), and medicated and
unmedicated OCD patients with 0.86 AUC (SD = 0.02, pcorr < .001).
F IGURE 2 Summary of the
subcortical volume effects in
ENIGMA-OCD (based on
Boedhoe et al., 2017
Am J Psychiatry)
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These multivariate results therefore mirror the univariate results, and
highlight that medication use is associated with significant differences
in brain anatomy.
In the second additional approach, we studied age-by-medication
interactions in 2,176 OCD patients (1,040 medicated/1,136
unmedicated) and 2,003 healthy controls, using a general linear model
(Ivanov et al., 2019). Medicated OCD patients, unmedicated OCD
patients, and healthy controls all showed decreasing brain-wide corti-
cal thickness, surface area, and subcortical volume with increasing age
(p < .0005) in most regions. Effects of medication (p < .001–.0005)
and age-by-medication interactions (p < .05–.0005) were detected in
46 cortical and 7 subcortical brain regions. Accordingly, in certain
regions (e.g., supramarginal gyrus, lateral occipital cortex), child and/or
adolescent medicated OCD patients had thicker cortex than
unmedicated patients. Adult medicated OCD patients, however, had
thinner cortex than unmedicated OCD patients. Effects on cortical
thickness were strongest for tricyclic antidepressants, but were also
present for serotonin reuptake inhibitors (SRIs) and benzodiazepines.
One (speculative) explanation of the differential effects of medication
on cortical thickness in pediatric versus adult patients with OCD is
the combination of treatment-associated slowing of the neuronal
regressive changes (synapse loss and neurite pruning) and slowing
(in children) and acceleration (in adults) of the progressive white-
matter myelination of normal aging.
1.4 | The first ENIGMA-OCD brain structural
connectivity results
After conducting the initial meta- and mega-analyses of regional brain
volumetric abnormalities, we initiated analyses of structural brain
connectivity, using both structural covariance graph analyses
(Yun et al., 2020) and diffusion tensor imaging (Piras et al., 2019). Brain
structural covariance networks reflect covariation in morphology of
different brain areas and are thought to reflect common trajectories in
brain development and maturation, as well as common effects of a
disorder (Hunt et al., 2016). Large-scale investigation of structural
covariance networks are therefore of specific interest when studying
neurodevelopmental disorders such as OCD that have chronic symp-
toms over the lifespan.
Using T1-weighted MRI derived measures of brain morphometry
(bilaterally-averaged values of 33 cortical surface areas, 33 cortical
thickness values, and six subcortical volumes) from OCD patients
(n = 1,616) and healthy controls (n = 1,463), we calculated intra-
individual brain structural covariance networks, in which edge weights
were proportional to the similarity between two brain morphological
features in terms of deviation from controls (z-score transformed; Yun
et al., 2020). We focused on measures of network segregation (clus-
tering and modularity), network integration (global efficiency), their
balance (small-worldness), and community membership. We also stud-
ied hub profiling of regional brain areas using measures of between-
ness, closeness, and eigenvector centrality. Individually calculated
network measures were integrated across the 37 ENIGMA-OCD
datasets using a meta-analytic approach. At the global level, compared
to healthy controls, OCD patients showed lower clustering
(p < .0001), modularity (p < .0001), small-worldness (p = .017), and
community membership, suggesting lower network segregation. At
the regional level, compared to healthy controls, OCD patients
showed lower (rank-transformed) centrality values for caudate and
thalamus volume, and surface area of paracentral cortex, suggesting
an altered distribution of brain hubs. Centrality, mainly of the cingu-
late and orbitofrontal areas, was associated with OCD disease dura-
tion, indicative of greater involvement of these regions with
chronicity.
Abnormalities in structural connectivity might be explained in
part by microstructural alterations in white matter. A number of the
ENIGMA-OCD sites (n = 19) also have diffusion tensor imaging
(DTI) scans of the same participants used in the analyses of the
T1-weighted MRI measures. We compared DTI-derived values for
fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity
(RD), and axial diffusivity (AD) in 25 brain regions of OCD patients
(n = 700 adults and 174 children/adolescents) and healthy controls
F IGURE 3 Summary of the cortical thickness effects in adult OCD patients compared to healthy controls in ENIGMA-OCD, in relation to
medication status (based on Boedhoe et al., 2018 Am J Psychiatry). Negative effect sizes d (ranging from light orange d = −0.05 to dark red
d = −0.15) indicate thinner cortex in OCD compared to controls
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(n = 645 adults and 144 children/adolescents) (Piras et al., 2019).
We meta-analyzed patient versus control differences across sites,
adjusted for age and sex, and investigated potential associations
with clinical characteristics, such as medication status, age of dis-
ease onset, duration of illness, and disease severity. Adult OCD
patients showed significantly lower FA in the sagittal stratum
(Cohen's d = −0.21) and posterior thalamic radiation (Cohen's d =
−0.26). Lower FA in the sagittal stratum was associated with a
younger age of onset (z = 2.71), longer duration of illness (z =
−2.09), and a higher percentage of medicated patients in the
cohorts studied (z = −1.98). No significant association with symptom
severity was detected. Pediatric OCD patients did not show any
detectable microstructural abnormalities compared to matched
healthy controls. These results suggest that in adult OCD patients
the reported microstructural alterations in projection and association
fibers to posterior brain regions are partly related to disease course
and medication status, and thus are likely more a consequence than
a cause of disease.
Since brain morphometry is plastic and changes under the influ-
ence of daily behavior and network function, the next level of under-
standing is to link these morphometric features of disease to
alterations in brain network function, using fMRI scans, both at rest
and during specific cognitive or emotional states.
1.5 | New perspectives with clinical relevance
The ENIGMA-OCD consortium has already demonstrated significant
scientific relevance by increasing our understanding of the disorder.
Large-scale worldwide collaboration has also been relevant to thinking
through more effective and efficient ways of doing science by bring-
ing together data, expertise, and a critical mass of investigators.
Regarding clinical significance, the machine learning analyses of mor-
phological measures of the brain are not yet valuable diagnostically
(Bruin et al., 2019), and we certainly do not need an MRI scan to diag-
nose OCD. However, performance is likely to improve with the inclu-
sion of multimodal features from diffusion-weighted and functional
MRI. However, several important lessons with clinical relevance have
emerged. One example is the unexpected, but robust finding that
medication status and disease chronicity both have a marked impact
on all brain measures analyzed to date. This has two direct implica-
tions: First, it emphasizes the importance of establishing longitudinal
studies to examine the beneficial and potential harmful effects of
medication on the developing brain and; second, the fact that disease
chronicity is related to marked morphological alterations of the brain
might provide additional incentive to invest in the implementation of
state-of-the-art interventions (e.g., exposure treatment requires sig-
nificant scale up across the globe) and the development of innovative
treatments for those who do not respond to first line interventions.
Another example of clinical relevance of ENIGMA-OCD is the
potential for discovering prognostic biomarkers, that is, the predic-
tion of treatment response based on morphometric and/or func-
tional brain signatures. For instance, response to cognitive behavior
therapy (CBT) has been linked to structural variability in the prefron-
tal cortex (Fullana et al., 2014; Hoexter et al., 2013) and activation
and connectivity of the amygdala (Fullana et al., 2017; Göttlich,
Krämer, Kordon, Hohagen, & Zurowski, 2015; Olatunji et al., 2014).
Prediction studies have been so far limited in sample size and there-
fore replicability of findings has been poor. We have now started
using data from ENIGMA-OCD samples with longitudinal clinical
data of 170 children with OCD (from nine sites) and 315 adults with
OCD (from seven sites), to study how variation in morphological
values (cortical thickness, surface area, and subcortical volumetry) is
related to variation in treatment response (Bertolin, Martinez-
Zalacain, Boedhoe, & Alonso, 2019). Moreover, we expect that mul-
timodal imaging approaches, combining data on morphological fea-
tures with measurements of white matter integrity and information
on network function using resting-state fMRI, will be more informa-
tive for predicting treatment response at the individual level using
machine learning analyses.
1.6 | Ongoing and future analyses within
ENIGMA-OCD
As already shown in previous meta-analyses across related mental dis-
orders, some neural correlates are common across mental disorders,
whereas others are more disorder-specific (Goodkind et al., 2015;
Radua et al., 2010). The ENIGMA consortium, with different working
groups using the same pipelines for data processing and data analysis,
is an ideal setting for studying common and distinct features of mental
disorders. Our first attempt to do so focused on neurodevelopmental
disorders in the impulsive-compulsive spectrum, comparing OCD with
ASD and ADHD. Using structural T1-weighted MRI scans from
151 cohorts worldwide with data from patients with OCD (n = 2,323),
ASD (n = 1,777), and ADHD (n = 2,271), and matched healthy controls
(n = 5,827), we performed a mega-analysis of cortical thickness, sur-
face area and subcortical volume across groups, with separate ana-
lyses for children (<12 years), adolescents (12–17 years), and adults
(>18 years) (Boedhoe et al., 2019). We found no shared alterations
among all three disorders (even with uncorrected analyses), while
shared alterations between any two disorders did not survive correc-
tion for multiple comparisons. Children with ADHD compared to
those with OCD had smaller hippocampal volumes. Children and ado-
lescents with ADHD also had smaller intracranial volume than control
children and those with OCD or ASD. Adults with ASD showed
thicker frontal cortices compared to adult controls and other clinical
groups. OCD-specific alterations were not found across different age-
groups and no surface area alterations were found across the disor-
ders. Based on the literature, future cross-disorder comparisons
between OCD and other anxiety disorders, as previously done by
Radua et al. (2010), as well as comparison with schizophrenia, which is
also characterized by a bigger pallidum (Van Erp et al., 2016) may be
useful.
Another direction of research that is currently in preparation is
the meta-analysis of resting-state functional MRI. Resting-state fMRI
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(rs-fMRI) can provide multiple measures of functional connectivity
that are thought to index the communication between distinct brain
regions. A recent meta-analysis based on reported findings in the liter-
ature found that multiple resting-state networks are affected in OCD
(Gursel et al., 2018). Moreover, a single-site study suggests that rs-
fMRI can predict the outcome of CBT (Reggente et al., 2018). To
obtain robust estimations of functional connectivity abnormalities in
OCD, the consortium aims to perform functional connectivity ana-
lyses using the fmriprep + pipeline that has been developed by Veer
and colleagues (Charité, Berlin). This pipeline uses the fMRI
preprocessing stages from fmriprep (Esteban et al., 2019), and outputs
various rs-fMRI measures such as resting-state networks based on
independent components analysis and (partial) correlation matrices
between distinct brain regions. Initially, the consortium will analyze
average group differences in these measures between OCD patients
and controls, and subsequently use machine-learning methods to
determine whether rs-fMRI can provide a biomarker for OCD. Fur-
thermore, the same methods will be used in order predict CBT out-
come at the group and individual patient level. We hope that this
endeavor will provide a biomarker for treatment outcome that gener-
alizes to different sites, and thereby paves the way towards personal-
ized treatment for OCD. In the future, we hope to extend rs-fMRI
meta-analysis in ENIGMA-OCD to task-based fMRI, focusing on fre-
quently used paradigms such as emotional processing, response inhi-
bition (and other executive tasks), and decision-making.
Advances in large-scale neuroimaging studies have allowed the
characterization of distinct group differences in the macroscopic
structure of the cerebral cortex, across several psychiatric disorders
(Thompson et al., 2019). Using a new bioinformatics approach, named
virtual histology, we can now link these macroscopic differences with
microscopic histological features within the human cerebral cortex
(Patel, Shin, Gowland, Pausova, & Paus, 2018; Shin et al., 2018). In
brief, virtual histology relates variation in cell-specific gene expression
profiles across the 34 regions of the Desikan-Killiany atlas with pro-
files of group differences in cortical thickness across the same
34 regions (Desikan et al., 2006). This approach combines gene
expression data from the Allen Human Brain Atlas (Hawrylycz et al.,
2012), and cell-specific markers from single-cell RNA sequencing
(Zeisel et al., 2015) with MRI derived measures. Profiles of group dif-
ferences in cortical thickness are generated using a meta-analytic
approach for each of six major psychiatric disorders (ASD, ADHD,
bipolar disorder, major depressive disorder, OCD, and schizophrenia).
Currently, there are 12,006 cases and 14,842 controls contributing to
these profiles. The goal of the project is to characterize cell types
within the human cortex (neurons [pyramidal cells and interneurons]
and glia [astrocytes, microglia, oligodendrocytes]) in which gene
expression is correlated with differences in cortical thickness across
disorders, in the hope of illustrating common and/or unique neurobio-
logical correlates between these disorders.
Ultimately we would like to combine imaging data with genetic
information. ENIGMA has developed pipelines for integrated analyses
of both neuroimaging and genetic data. Some of this work has
focused on common variants: Satizabal et al. (2019), for example,
investigated nearly 40,000 individuals, and found that more than
45 genetic loci were significantly associated with subcortical volumes.
Analyses indicated that associated genes are implicated in neuro-
development, synaptic signaling, axonal transport, and other key pro-
cesses. Other work has focused on CNVs: in the largest CNV
neuroimaging study to date, for example, 15q11.2 BP1-BP2 structural
variation was found associated with brain morphology and cognition,
with deletion carriers being particularly affected (Writing Committee
for the ENIGMA-CNV Working Group., 2019). There is a clear poten-
tial to extend such work to specific disorders such as OCD. In a proof
of principle investigation, ENIGMA-OCD has explored the overlap in
genetic contributions to subcortical volumes and OCD (Hibar et al.,
2018); significant positive concordance was found between OCD risk
variants and variants associated with greater nucleus accumbens and
putamen volumes. Further work is needed to expand on these prelimi-
nary findings. While the combined imaging-genetics database is still
small, a polygenic risk score approach may be a useful first step.
1.7 | Limitations of the ENIGMA approach
Three important methodological weaknesses of the ENIGMA-OCD
concept should be mentioned. First, the data collection was done in
the past, at a time when there was no plan to use the data in world-
wide collaboration. Therefore, there has been no harmonization of
data acquisition, either with respect to imaging data or with respect to
inclusion criteria and clinical data. Various MRI machines (with differ-
ent field strengths) and various scan sequences have been used with
inevitable variations in data quality. In addition, the level of detail on
the clinical phenotypes (disease severity, comorbidity, disease course,
treatment history, etc.) is limited, so disallowing detailed analyses of
symptom profiles or cross-disorder characteristics. Second, the data
collection has been mostly cross-sectional, limiting our ability to
answer questions related to disease course, effects of medication, and
cause versus consequence of disease. Longitudinal data is highly
warranted, and with the increase in pre-/post-treatment imaging stud-
ies, we expect that more longitudinal data will soon become available.
Family and particularly twin studies could go a long way to disentan-
gle vulnerability from disease chronicity and medication. Third, only
some of the imaging samples also have genotyping data, presenting a
challenge, since for imaging-genetic analyses large samples are
needed.
1.8 | Summary and future directions in global
collaborations
ENIGMA-OCD has brought together OCD experts from all over the
world to re-analyze historical MRI data using meta- and mega-ana-
lyses. This has not only resulted in important contributions to the lit-
erature on brain alterations in OCD, but has also stimulated
international collaboration and sharing of OCD imaging data from
sites across the globe. While as outlined earlier, there are many
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questions still to address in the growing ENIGMA-OCD dataset, the
findings and the successful model of international collaboration have
already spurred new studies. For example, to address the lack of har-
monization of data acquisition and the lack of detail on clinical profile,
and to address the confound of medication in the ENIGMA-OCD
dataset, five of the participating ENIGMA-OCD sites, representing
five continents, are now funded by NIMH (PI: H. Blair Simpson) to
conduct the largest neurocognitive and multimodal-imaging study in
medication-free subjects with OCD to date. Specifically, we will
recruit 250 medication-free adults with OCD, 100 unaffected adult
siblings of individuals with OCD, and 250 healthy control subjects. All
will receive clinical evaluation, neurocognitive assessment, and MRI,
focusing on morphometry (T1-weighted MRI), structural connectivity
(DTI), and functional connectivity (rs fMRI). To ensure harmonized
data collection, we have developed detailed protocols to ensure
cross-site reliability on clinical measures, standardized delivery of
neurocognitive tasks, and optimal MRI data acquisition for data
pooling (see Simpson et al., 2020 for details). Following best-practices
used in large-scale imaging consortia, the MRI quality procedures
include: Harmonization of scan sequences to optimize scan quality
across scanners; both human and physical phantom studies at study
start, with repeat phantom studies and preprocessing of all scans in
real-time to ensure maintenance of scan quality over the course of
study recruitment. Other ENIGMA-OCD sites that start new data col-
lection might consider using similar methods, to increase the number
of samples with higher quality harmonized data.
To conclude, large-scale data-sharing as facilitated by ENIGMA-
OCD has accelerated discovery and generated novel hypotheses that
are now being pursued. It has also created a model for large-scale
global collaboration across OCD experts, and even more broadly,
across working groups focused on a range of disorders and methodol-
ogies. By joining forces, we can help to shift the research model from
local and mono-disciplinary to global and multidisciplinary, increase
rigor and transparency, and accelerate discovery. In the end, we share
a common goal: To develop a circuit-based approach to different cog-
nitive and clinical dimensions of OCD that can help transform how
OCD and related mental disorders are conceptualized, diagnosed, and
ultimately treated around the world.
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